6 completed, 3 terminated. 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 6, Terminated 3 |
Follow becatecarin: new trials by email Literature Review of becatecarin trials Research Report on becatecarin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy becatecarin - Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 21 | 2004-04-01 | 2014-05-23 |
| Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer becatecarin - Ovarian Cancer | Phase 2 | Terminated | Northwestern University | 2000-07-01 | 2012-06-11 | |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma becatecarin - Brain and Central Nervous System Tumors, Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 200 | 2000-07-01 | 2013-02-05 |
| Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer becatecarin - Kidney Cancer | Phase 2 | Completed | Barbara Ann Karmanos Cancer Institute | 2000-06-01 | 2013-04-05 | |
| Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer becatecarin - Lung Cancer | Phase 2 | Completed | Case Comprehensive Cancer Center | 42 | 2000-05-01 | 2010-06-10 |
| Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer becatecarin, laboratory biomarker analysis - Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 42 | 2000-03-01 | 2013-02-01 |
| Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer becatecarin - Colorectal Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 37 | 2000-02-01 | 2013-02-11 |
| Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer becatecarin - Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 2 | Terminated | Case Comprehensive Cancer Center | 72 | 1999-04-01 | 2010-06-11 |
| Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma becatecarin - Neuroblastoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 30 | 1999-01-01 | 2013-06-25 |
Neuroblastoma (2) · Astrocytoma (1) · Bile Duct Neoplasms (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Burkitt Lymphoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Central Nervous System Neoplasms (1) · Choroid Plexus Neoplasms (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Dendritic Cell Sarcoma, Interdigitating (1)
National Cancer Institute (NCI) (4) · Case Comprehensive Cancer Center (2) · Barbara Ann Karmanos Cancer Institute (1) · Memorial Sloan Kettering Cancer Center (1) · Northwestern University (1)
United States (9) · Australia (1) · Canada (1) · Netherlands (1) · New Zealand (1) · Puerto Rico (1) · Switzerland (1)
Afshin Dowlati, MD (2) · Afshin Dowlati (1) · Anne-Marie Langevin, MD (1) · David A. Fishman, MD (1) · Harold Burstein (1) · Sridhar Mani, MD (1) · Tanya Trippett, MD (1) · Ulka N. Vaishampayan, MD (1)
P30CA043703 (3), U01CA062502 (2), U01CA063200 (2), P30CA022453 (1), U01CA062487 (1)